Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

It gets tricky fast': benefits lawyer outlines legal pitfalls of HR offering – or not offering – weight loss drugs in Canada ...

If your constipation lasts for more than 3 days, speak with your doctor about options to help. You might need to add a stool ...

Researchers took drugs currently used to treat type 2 diabetes and obesity and looked into how they affect 175 conditions.

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

Only 34 of 79 websites stated that compounded drugs were not FDA approved; 39 websites did not report adverse effects, warnings.

Oikos and its other popular brands are seeing a spike in demand as people taking the weight-loss medications turn to the portion-controlled snacks to meet their nutritional needs.

With a strategic focus on innovation and a robust operational framework, Medifast is well-placed for growth in the weight loss and GLP-1 medication space.

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making ...

Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...